EDAP TMS reported EUR8.15M in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
AngioDynamics USD 44.78M 2.93M Sep/2025
Boston Scientific USD 3.82B 210M Jun/2026
EDAP TMS EUR 8.15M 2.17M Mar/2026
Henry Schein USD 1.03B 39M Jun/2026
Medtronic USD 6.01B 595M Mar/2026
Plus Therapeutics 1.37M 30K Dec/2025
Veracyte USD 108.55M 7.39M Jun/2026